Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele Marfella

Showing results (231-240 of 306) with videos related to

Pageof 31
Sort By:
Experimental Diabetes Research|December 1, 2012
Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetesRaffaele Marfella, Ferdinando Carlo Sasso, Maria Rosaria Rizzo, et al.
Cardiovascular Diabetology|April 3, 2023
SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive coronary artery stenosisCelestino Sardu, Maria Consiglia Trotta, Ferdinando Carlo Sasso, et al.
The Journal of Clinical Endocrinology and Metabolism|January 18, 2011
Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidismRaffaele Marfella, Franca Ferraraccio, Maria Rosaria Rizzo, et al.
Molecular Medicine (Cambridge, Mass.)|June 4, 2011
Altered oxido-reductive state in the diabetic heart: loss of cardioprotection due to protein disulfide isomeraseStefano Toldo, Mariarosaria Boccellino, Barbara Rinaldi, et al.
European Journal of Heart Failure|June 6, 2013
Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-respondersRaffaele Marfella, Clara Di Filippo, Nicoletta Potenza, et al.
Cardiovascular Diabetology|November 7, 2022
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trialFerdinando Carlo Sasso, Vittorio Simeon, Raffaele Galiero, et al.
Cardiovascular Diabetology|December 29, 2018
Correction to: Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-upCelestino Sardu, Michelangela Barbieri, Maria Luisa Balestrieri, et al.
Annual Review of Pharmacology and Toxicology|January 23, 2026
Microplastics and Atherosclerosis: MechanismsRaffaele Marfella, Francesco Prattichizzo, Michelangela Barbieri, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 2, 2020
Aspirin in a diabetic retinopathy setting: Insights from NO BLIND studyPia Clara Pafundi, Raffaele Galiero, Alfredo Caturano, et al.
Pharmacological Research|May 6, 2025
Effects of SGLT2i therapy on cardiac electrophysiological properties and arrhythmias in diabetic patients with implantable cardiac defibrillatorCelestino Sardu, Maria Consiglia Trotta, Ludovica Vittoria Marfella, et al.
Pageof 31

Showing results (231-240 of 306) with videos related to

Sort By:
Pageof 31
Experimental Diabetes Research|December 1, 2012
Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetesRaffaele Marfella, Ferdinando Carlo Sasso, Maria Rosaria Rizzo, et al.
Cardiovascular Diabetology|April 3, 2023
SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive coronary artery stenosisCelestino Sardu, Maria Consiglia Trotta, Ferdinando Carlo Sasso, et al.
The Journal of Clinical Endocrinology and Metabolism|January 18, 2011
Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidismRaffaele Marfella, Franca Ferraraccio, Maria Rosaria Rizzo, et al.
Molecular Medicine (Cambridge, Mass.)|June 4, 2011
Altered oxido-reductive state in the diabetic heart: loss of cardioprotection due to protein disulfide isomeraseStefano Toldo, Mariarosaria Boccellino, Barbara Rinaldi, et al.
European Journal of Heart Failure|June 6, 2013
Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-respondersRaffaele Marfella, Clara Di Filippo, Nicoletta Potenza, et al.
Cardiovascular Diabetology|November 7, 2022
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trialFerdinando Carlo Sasso, Vittorio Simeon, Raffaele Galiero, et al.
Cardiovascular Diabetology|December 29, 2018
Correction to: Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-upCelestino Sardu, Michelangela Barbieri, Maria Luisa Balestrieri, et al.
Annual Review of Pharmacology and Toxicology|January 23, 2026
Microplastics and Atherosclerosis: MechanismsRaffaele Marfella, Francesco Prattichizzo, Michelangela Barbieri, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 2, 2020
Aspirin in a diabetic retinopathy setting: Insights from NO BLIND studyPia Clara Pafundi, Raffaele Galiero, Alfredo Caturano, et al.
Pharmacological Research|May 6, 2025
Effects of SGLT2i therapy on cardiac electrophysiological properties and arrhythmias in diabetic patients with implantable cardiac defibrillatorCelestino Sardu, Maria Consiglia Trotta, Ludovica Vittoria Marfella, et al.
Pageof 31